46,644 Shares in Envista Holdings Corporation $NVST Purchased by ARGA Investment Management LP

ARGA Investment Management LP bought a new position in Envista Holdings Corporation (NYSE:NVST) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 46,644 shares of the company’s stock, valued at approximately $950,000.

Several other institutional investors also recently made changes to their positions in NVST. Holocene Advisors LP bought a new stake in shares of Envista in the 2nd quarter worth approximately $43,936,000. Norges Bank acquired a new stake in Envista in the second quarter worth $40,229,000. Alliancebernstein L.P. increased its position in Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after buying an additional 1,547,656 shares during the period. Franklin Resources Inc. lifted its stake in Envista by 16.7% in the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock valued at $175,011,000 after buying an additional 1,284,767 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Envista by 22.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,905,149 shares of the company’s stock valued at $59,178,000 after acquiring an additional 523,949 shares during the period.

Envista Price Performance

NYSE NVST opened at $23.86 on Friday. Envista Holdings Corporation has a 12 month low of $14.22 and a 12 month high of $25.41. The firm has a market capitalization of $3.92 billion, a PE ratio of 265.10, a P/E/G ratio of 1.09 and a beta of 0.99. The company’s 50 day simple moving average is $21.95 and its 200 day simple moving average is $20.93. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Envista had a return on equity of 5.90% and a net margin of 0.58%.The firm had revenue of $669.90 million during the quarter, compared to analyst estimates of $639.49 million. During the same period last year, the company posted $0.12 EPS. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, equities research analysts forecast that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

NVST has been the topic of several recent research reports. Mizuho set a $24.00 price objective on shares of Envista and gave the company a “neutral” rating in a research report on Tuesday. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a report on Sunday, January 18th. Barclays began coverage on Envista in a research report on Monday, December 8th. They set an “overweight” rating and a $24.00 price objective for the company. Robert W. Baird set a $27.00 target price on Envista in a research report on Friday, October 31st. Finally, Stifel Nicolaus set a $25.00 price target on Envista in a research report on Thursday, October 30th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Envista presently has an average rating of “Hold” and a consensus price target of $22.17.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.